Clover Health Investments, Corp.
NASDAQ:CLOV
3 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 122.863 | 103.791 | 299.968 | 28.003 | 67.598 | 75.403 |
| Short Term Investments
| 119.822 | 230.97 | 315.287 | 123.1 | 0 | 0 |
| Cash and Short Term Investments
| 242.685 | 555.293 | 791.194 | 151.103 | 67.598 | 75.403 |
| Net Receivables
| 113.832 | 147.158 | 62.324 | 84.942 | 0 | 0 |
| Inventory
| 70.049 | -101.884 | -153.917 | -208.042 | 0 | 0 |
| Other Current Assets
| 1.404 | 24.43 | 52.945 | 0.3 | 0 | 0 |
| Total Current Assets
| 427.97 | 624.997 | 752.546 | 28.303 | 67.598 | 75.403 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 8.464 | 9.778 | 7.654 | 9.96 | 13.037 | 3.211 |
| Goodwill
| 0 | 11.749 | 1.243 | 1.233 | 1.243 | 0 |
| Intangible Assets
| 2.99 | 8.251 | 2.99 | 3 | 2.99 | 2.99 |
| Goodwill and Intangible Assets
| 2.99 | 20 | 4.233 | 4.233 | 4.233 | 2.99 |
| Long Term Investments
| 121.001 | 138.11 | 175.939 | 4.363 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | -18.556 | 0 | 0 |
| Other Non-Current Assets
| 10.246 | 15.735 | 10.432 | 828.117 | -17.17 | 128.993 |
| Total Non-Current Assets
| 142.701 | 183.623 | 198.258 | 828.117 | 0.1 | 135.194 |
| Total Assets
| 570.671 | 808.62 | 950.804 | 267.252 | 0.1 | 210.597 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 37.184 | 32.445 | 28.129 | 30.671 | 0 | 0 |
| Short Term Debt
| 1.665 | 1.827 | 3.059 | 0.806 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 141.692 | 141.947 | 165.868 | 102.429 | 0 | 0 |
| Other Current Liabilities
| 80.574 | 264.437 | 175.568 | -99.972 | 0.118 | 0 |
| Total Current Liabilities
| 261.115 | 440.656 | 372.624 | 33.934 | 0.118 | 6.027 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 2.998 | 4.033 | 24.768 | 106.413 | 57.917 | 49.252 |
| Deferred Revenue Non-Current
| 3.099 | 0 | 0 | 28.98 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -3.099 | 0 | 0 | -135.393 | 0 | 0 |
| Other Non-Current Liabilities
| 20.164 | 16.193 | 14.095 | 28.98 | -57.917 | 210.145 |
| Total Non-Current Liabilities
| 23.162 | 20.226 | 38.863 | 28.98 | 57.917 | 259.397 |
| Total Liabilities
| 284.277 | 460.882 | 411.487 | 835.635 | 0.118 | 265.424 |
| Equity: | ||||||
| Preferred Stock
| 316.2 | 395.069 | 616.037 | 447.747 | 447.747 | 447.747 |
| Common Stock
| 0.049 | 0.046 | 0.046 | 788.509 | 0.009 | 0.004 |
| Retained Earnings
| -2,159.794 | -1,955.582 | -1,616.738 | -6.762 | -0.018 | -527.896 |
| Accumulated Other Comprehensive Income/Loss
| -2.37 | -9.374 | -1.934 | 0.01 | -850.843 | -0 |
| Other Total Stockholders Equity
| 2,132.309 | 1,917.579 | 1,541.906 | -1,797.886 | 403.087 | 25.318 |
| Total Shareholders Equity
| 286.394 | 347.738 | 539.317 | -568.383 | -0.018 | -54.827 |
| Total Equity
| 286.394 | 347.738 | 543.22 | -564.48 | -0.018 | -54.827 |
| Total Liabilities & Shareholders Equity
| 570.671 | 808.62 | 950.804 | 267.252 | 0.1 | 210.597 |